UnitedHealth vs Eli Lilly: OVR ratings, revenue growth, valuation, and volatility compared.
UNH — Largest US insurer + Optum healthcare services. OVR: 88 (S-Tier).
LLY — Obesity drug empire. Mounjaro/Zepbound demand exceeds supply. OVR: 91 (S-Tier).
| METRIC | UNH — UnitedHealth | LLY — Eli Lilly |
|---|---|---|
| OVR Rating | 88 | 91 |
| Tier | S-Tier | S-Tier |
| Momentum Score | 58/100 | 80/100 |
| Stability Score | 88/100 | 85/100 |
| Value Score | 68/100 | 50/100 |
| Revenue Growth | +9% | +36% |
| P/E Ratio | 18x | 48x |
| Beta | 0.6 | 0.65 |
| Market Cap | $460B | $740B |
| Dividend Yield | 1.5% | 0.6% |
| S&P 500 | Yes | Yes |
Educational purposes only. MarketMVP OVR scores and ratings are educational tools — not financial advice or recommendations. Always do your own research. Full disclaimer